Spanish Association Against Cancer [PROYE18061FERN]; Asturias Government (PCTI) [IDI/2018/146]; Fundacion General CSIC [0348_CIE_6_E]; Health Institute Carlos III (Plan Nacional de I+D+I); FEDER, European Commission [PI18/01527] (.) Work in the laboratory of M.S. was funded by the IRB and by grants from the Spanish Ministry of Economy co-funded by the European Regional Development Fund (SAF2017-82613-R), ERC (ERC-2014-AdG/669622) (.)
The Asturias Government (PCTI) co-funding 2018-2022/FEDER (IDI/2018/146 to M.F.F.), the Fundación General CSIC (0348_CIE_6_E to M.F.F.), the Health Institute Carlos III (Plan Nacional de I+D+I) co-funding FEDER (PI18/01527 to M.F.F and A.F.F.), the MINECO (DEP2015-69980-P to B.F.G.). R.G.U. is supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). J.R.T. is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation MCIN/AEI/10.13039/ 501100011033 (IJC2018-036825-I) (.) ; Urdinguio, RG; Tejedor, JR; Fernandez-Sanjurjo, M; Perez, RF; Penarroya, A; Ferrero, C; Codina-Martinez, H; Diez-Planelles, C; Pinto-Hernandez, P; Castilla-Silgado, J; Coto-Vilcapoma, A; Diez-Robles, S; Blanco-Agudin, N; Tomas-Zapico, C; Iglesias-Gutierrez, E; Fernandez-Garcia, B; Fernandez, AF; Fraga, MF
This work was supported by grants to AB from the Spanish Ministry of Economy, Industry (SAF2015-70882-R; AEI/FEDER, UE), Comunidad Auto´noma de Madrid (S2010/BMD-2420), Instituto Salud Carlos III (RETICS TerCel, RD12/0019/0018) and the European Commission (FP7-HEALTH2009/CARE-MI). AMS was supported by grants from the MINECO (SAF2010–17167) and Instituto Salud Carlos III (RETICS TerCel, RD12/0019/0013), and MFF and RGU by grants from the Plan Nacional de I+D+I 2013-2016/FEDER (PI15/ 00892), the Asturias Regional Government (GRUPIN14-052), the IUOPA (Obra Social Cajastur) and the Fundacio´n Cientı´fica de la AECC. SGL held a predoctoral fellowship from the Spanish Programa de Formacio´n del Profesorado Universitario.
This work has been financially supported by the Plan Nacional de I + D + I 2008–2011/2013–2016/FEDER (PI11/01728 to A.F.F.; PI12/01080 and PI15/00892 to M.F.F.; PI 12/0615 to J.A.R.; PI05/2217 and PI08/0029 to J.G-C); the ISCIII-Subdirección General de Evaluación y Fomento de la Investigación (Miguel Servet contract: CP11/00131 to A.F.F.); IUOPA (to G.F.B. and M.S); Fundacion Cientifica de la AECC (to R.G.U.); Fundación Ramón Areces (to M.F.F); and FICYT (to E.G.T., M.G.G and A.C.);the Madrid Regional Government (S-BIO-02042006 and S2010/BMD-2420 to J.G-C) and the Asturias Regional Government (GRUPIN14-052 to M.F.F.). The IUOPA is supported by the Obra Social Cajastur, Spain. ; Toraño, E.G., Bayón, G.F., del Real, Á., Sierra, M.I., García, M.G., Carella, A., Belmonte, T., Urdinguio, R.G., Cubillo, I., García-Castro, J., Delgado-Calle, J., Pérez-Campo, F.M., Riancho, J.A., Fraga, M.F., Fernández, A.F.
This work has been financially supported by: the Plan Nacional de I+D+I 2013-2016/FEDER (PI15/00892 to M.F.F. and A.F.F.); the ISCIII-Subdirección General de Evaluación y Fomento de la Investigación, and the Plan Nacional de I+D+I 2008-2011/FEDER (CP11/00131 to A.F.F.); IUOPA (to G.F.B., M.I.S. and C.M.); the Fundación Científica de la AECC (to R.G.U.); FICYT (to M.G.G. and A.C.); and the Asturias Regional Government (GRUPIN14-052 to M.F.F.). A.F.F. is also supported from Ministerio de Economía y Competitividad and the European Regional Development Fund (FEDER), Programa Retos de la Sociedad 2015 (RTC-2015-3393-1). The IUOPA is supported by the Obra Social CajasturLiberbank, Spain. ; García, M.G., Carella, A., Urdinguio, R.G., Bayón, G.F., Lopez, V., Tejedor, J.R., Sierra, M.I., García-Toraño, E., Santamarina, P., Perez, R.F., Mangas, C., Astudillo, A., Corte-Torres, M.D., Sáenz-de-Santa-María, I., Chiara, M.-D., Fernández, A.F., Fraga, M.F.
Plan Nacional de I+D+I Instituto de Salud Carlos III [PI11/00929]; Plan Nacional de I+D+I ISCIII [CP13/00013, PI13/00259]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Spain [RD12/0036/0015]; Fundacion Bancaria Caja de Ahorros de Asturias-IUOPA; FEDER Funding Program from the European Union; ISCIII [CD13/00157]; PFIS ISCIII [FI12/00415]
Plan Nacional de I+D+I co-funding FEDER [PI15/00892 and PI18/01527 to M.F.F. and A.F.F.; PI16/01318 and PI14/01244 to C.L.]; ISCIII-Subdireccion General de Evaluación y Fomento de la Investigación, and Plan ´ Nacional de I+D+I 2008–2011/FEDER [CP11/00131 to A.F.F.]; IUOPA (to G.F.B. and M.I.S.); Fundación Científica de la AECC (to R.G.U.); Ministry of Economy and Competitiveness Juan de la Cierva postdoctoral fellowships [FJCI-2015-26965 to J.R.T., IJCI-2015- 23316 to V.L.]; Fundación Ramón Areces (to M.F.F); ´ FICYT (to E.G.T., M.G.G., A.C.); Asturias Regional Government [GRUPIN14-052 to M.F.F.]; Gobierno del Principado de Asturias, PCTI-Plan de Ciencia, Tecnología e Innovación co-funding Fondos FEDER (grant number IDI/2018/146 to M.F.F. and IDI/2018/144 to C.L.); Spanish Ministry of Economy and Competitiveness [SAF-SAF2013-43065 to P.M.]; Asociación Española Contra el Cáncer [AECC-CI-2015]; FERO Foundation, and the ISCIII [PI14-01191 to C.B.]; P.M. acknowledges financial support from The Obra Social La Caixa Fundación Josep Carreras and The Generalitat de Catalunya (SGR330). P.M. an investigator from the Spanish Cell Therapy cooperative network (TERCEL). The IUOPA is supported by the Obra Social Liberbank-Cajastur, Spain. Funding for open access charge: Plan Nacional de I+D+I co-funding FEDER [PI18/01527]. ; Urdinguio, R.G., Lopez, V., Bayón, G.F., Diaz De La Guardia, R., Sierra, M.I., García-Toraño, E., Perez, R.F., García, M.G., Carella, A., Pruneda, P.C., Prieto, C., Dmitrijeva, M., Santamarina, P., Belmonte, T., Mangas, C., Diaconu, E., Ferrero, C., Tejedor, J.R., Fernandez-Morera, J.L., Bravo, C., Bueno, C., Sanjuan-Pla, A., Rodriguez, R.M., Suarez-Alvarez, B., López-Larrea, C., Bernal, T., Colado, E., Balbín, M., García-Suarez, O., Chiara, M.D., Sáenz-De-Santa-María, I., Rodríguez, F., Pando-Sandoval, A., Rodrigo, L., Santos, L., Salas, A., Vallejo-Díaz, J., C Carrera, A., Rico, D., Hernández-López, I., Vayá, A., Ricart, J.M., Seto, E., Sima-Teruel, N., Vaquero, A., Valledor, L., Cañal, M.J., Pisano, D., ...
This work was supported by the Spanish Association Against Cancer (PROYE18061 FERN to M.F.F.), the Asturias Government (PCTI) cofunding 2018- 2022/FEDER (IDI/2018/146 to M.F.F.), Fundación General CSIC (0348_CIE_6_E to M.F.F.), and the Health Institute Carlos III (Plan Nacional de I þ DþI) cofunding FEDER (PI15/00892 and PI18/01527 to M.F.F and A.F.F.). They also acknowledge support from the Ramón Areces Foundation (CIVP18A3891 to P.J.F.M.), the AECC (SIRTBIO to P.J.F.M.), the MICINN (SAF2017-85766-R to P.J.F.M.), a Ramón y Cajal fellowship (MICINN, RYC-2017-22335 to P.J.F.M.), and the European Commission ATTRACT project (777222 to A.P.C.). J.R.T. is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation (FJCI-2015-26965). R.F.P. and P.S.O. are supported by the Severo Ochoa program (BP17-114 and BP17-165, respectively). R.G.U. is supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (Health Institute Carlos III). L.V. was supported by the UAB Predoctoral training programme (PIF predoctoral fellowships). They also acknowledge support from the IMDEA Food Institute and IUOPA-ISPA-FINBA (the IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain).
This work has been financially supported by: the Plan Nacional de IþDþI 2013–2016/FEDER (PI15/00892 to M.F.F. and A.F.F.; RTC2015-3393-1 to A.F.F.); the ISCIII-Subdirección General de Evaluación y Fomento de la Investigación, and the Plan Nacional de IþDþI 2008–2011/FEDER (CP11/00131 to A.F.F.); IUOPA (to G.F.B. and M.S); the Fundación Científica de la AECC (to R.G.U.); the Fundación Ramón Areces (to M.F.F); FICYT (to E.G.T., M.G.G. and A.C.); and the Asturias Regional Government (GRUPIN14-052 to M.F.F.). Work in P.M. laboratory is supported by the European Research Council (CoG-2014-646903), the Spanish Ministry of Economy-Competitiveness (SAF-SAF2013-43065), the Obra Social La Caixa-Fundació Josep Carreras, and the Generalitat de Catalunya. P.M. is an investigator in the Spanish Cell Therapy cooperative network (TERCEL). The IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain. ; Fernandez, A.F., Bayón, G.F., Sierra, M.I., Urdinguio, R.G., Toraño, E.G., García, M.G., Carella, A., López, V., Santamarina, P., Pérez, R.F., Belmonte, T., Tejedor, J.R., Cobo, I., Menendez, P., Mangas, C., Ferrero, C., Rodrigo, L., Astudillo, A., Ortea, I., Díaz, S.C., Rodríguez-Gonzalez, P., Alonso, J.I.G., Mollejo, M., Meléndez, B., Domínguez, G., Bonilla, F., Fraga, M.F.
This work has been financially supported by the Plan Nacional de I+D+I 2013-2016/FEDER (PI15/00892 to M.F.F. and A.F.F.), the ISCIII-Subdirección General de Evaluación y Fomento de la Investigación (Miguel Servet contract CP11/00131 to A.F.F.); the Asturias Regional Government (GRUPIN14-052 to M.F.F.); FICYT (A.C. and M.G.); the Ministry of Economy and Competitiveness of Spain (J.R.T., Juan de la Cierva fellowship FJCI-2015-26965, V.L., Juan de la Cierva fellowship IJCI-2015-23316); Fundación Científica de la AECC (to R.G.U.); FINBA-ISPA (R.F.P.); IUOPA (G.F.B. and C.M.) and Fundación Ramón Areces (M.F.F.). A.F.F. is also financially supported by the Ministry of Economy and Competitiveness of Spain, the European Regional Development Fund (FEDER) and the Programa Retos de la Sociedad (RTC-2015-3393-1). The IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain.
